Description

Pramipexol ІC (pramipexole) tablets 0.25 mg. № 30

Ingredients:

Each tablet contains 0.25 mg of pramipexole.

Dosage:

The recommended dosage is determined by a healthcare provider. Typically, the starting dose for Parkinson’s disease is 0.125 mg three times daily, which can be increased gradually.

Indications:

Pramipexol ІC tablets are indicated for the treatment of Parkinson’s disease and Restless Legs Syndrome (RLS). It works by stimulating dopamine receptors in the brain, improving motor symptoms in Parkinson’s and reducing the urge to move legs in RLS.

Contraindications:

Do not use Pramipexol ІC if you are allergic to pramipexole or have severe kidney problems. It is important to inform your doctor about any medical conditions or medications you are taking before starting this medication.

Directions:

Take Pramipexol ІC tablets exactly as prescribed by your healthcare provider. It is usually taken orally with or without food. Do not crush or chew the tablets.

Scientific Evidence:

Pramipexole, the active ingredient in Pramipexol ІC tablets, has been extensively studied for its efficacy in treating Parkinson’s disease and RLS. Research published in the *Journal of Neural Transmission* has shown that pramipexole significantly improves motor symptoms and quality of life in Parkinson’s patients. Additionally, a meta-analysis in the *Journal of Clinical Pharmacology* concluded that pramipexole is effective and well-tolerated in the treatment of RLS.

Additional Information:

In clinical trials, Pramipexol ІC has demonstrated a favorable safety profile and significant improvement in both motor and non-motor symptoms of Parkinson’s disease. Patients have reported reduced tremors, stiffness, and improved mobility with the use of pramipexole. It is important to follow up with your healthcare provider regularly to monitor the effectiveness and any potential side effects of this medication.

Pharmacologically, pramipexole is a dopamine agonist that directly stimulates dopamine receptors in the brain. By mimicking the action of dopamine, it helps regulate movement and mood in patients with Parkinson’s disease. Compared to other dopamine agonists, pramipexole has shown superior efficacy and tolerability, making it a preferred choice for many healthcare providers.

Overall, Pramipexol ІC tablets offer a well-established treatment option for Parkinson’s disease and Restless Legs Syndrome. With strong scientific evidence supporting its efficacy and safety, this medication continues to be a valuable asset in managing these neurological conditions.